150 related articles for article (PubMed ID: 37852029)
21. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
Dobrovolskaia MA; Aggarwal P; Hall JB; McNeil SE
Mol Pharm; 2008; 5(4):487-95. PubMed ID: 18510338
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
Nienhaus K; Nienhaus GU
Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
[TBL] [Abstract][Full Text] [Related]
23. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.
Brambilla D; Verpillot R; Le Droumaguet B; Nicolas J; Taverna M; Kóňa J; Lettiero B; Hashemi SH; De Kimpe L; Canovi M; Gobbi M; Nicolas V; Scheper W; Moghimi SM; Tvaroška I; Couvreur P; Andrieux K
ACS Nano; 2012 Jul; 6(7):5897-908. PubMed ID: 22686577
[TBL] [Abstract][Full Text] [Related]
24. Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona.
Li Z; Wang Y; Zhu J; Zhang Y; Zhang W; Zhou M; Luo C; Li Z; Cai B; Gui S; He Z; Sun J
J Control Release; 2020 Apr; 320():1-18. PubMed ID: 31931050
[TBL] [Abstract][Full Text] [Related]
25. Polyglycerol Grafting Shields Nanoparticles from Protein Corona Formation to Avoid Macrophage Uptake.
Zou Y; Ito S; Yoshino F; Suzuki Y; Zhao L; Komatsu N
ACS Nano; 2020 Jun; 14(6):7216-7226. PubMed ID: 32379425
[TBL] [Abstract][Full Text] [Related]
26. Impact of protein coronas on nanoparticle interactions with tissues and targeted delivery.
Chou WC; Lin Z
Curr Opin Biotechnol; 2024 Feb; 85():103046. PubMed ID: 38103519
[TBL] [Abstract][Full Text] [Related]
27. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
Butkovich N; Li E; Ramirez A; Burkhardt AM; Wang SW
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1681. PubMed ID: 33164326
[TBL] [Abstract][Full Text] [Related]
28. Polyethylene glycol (PEG) as a broad applicability marker for LC-MS/MS-based biodistribution analysis of nanomedicines.
Hyldbakk A; Hansen T; Hak S; Borgos SEF
J Control Release; 2024 Feb; 366():611-620. PubMed ID: 38215988
[TBL] [Abstract][Full Text] [Related]
29. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
30. The protein corona and its effects on nanoparticle-based drug delivery systems.
Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
[TBL] [Abstract][Full Text] [Related]
31. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles.
Su G; Jiang H; Xu B; Yu Y; Chen X
Mol Pharm; 2018 Nov; 15(11):5019-5030. PubMed ID: 30222356
[TBL] [Abstract][Full Text] [Related]
32. Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery.
Saiding Q; Zhang Z; Chen S; Xiao F; Chen Y; Li Y; Zhen X; Khan MM; Chen W; Koo S; Kong N; Tao W
Adv Drug Deliv Rev; 2023 Dec; 203():115116. PubMed ID: 37871748
[TBL] [Abstract][Full Text] [Related]
33. The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates.
Pitek AS; Wen AM; Shukla S; Steinmetz NF
Small; 2016 Apr; 12(13):1758-69. PubMed ID: 26853911
[TBL] [Abstract][Full Text] [Related]
34. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticle Surface Engineering with Heparosan Polysaccharide Reduces Serum Protein Adsorption and Enhances Cellular Uptake.
Yang W; Wang L; Fang M; Sheth V; Zhang Y; Holden AM; Donahue ND; Green DE; Frickenstein AN; Mettenbrink EM; Schwemley TA; Francek ER; Haddad M; Hossen MN; Mukherjee S; Wu S; DeAngelis PL; Wilhelm S
Nano Lett; 2022 Mar; 22(5):2103-2111. PubMed ID: 35166110
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Nanomedicine Tissue Distribution and Stability by Alexa Fluor 488 and PEG Immunohistochemistry.
Ware TD; Butcher D; Edmondson E; Stern ST
Methods Mol Biol; 2024; 2789():313-322. PubMed ID: 38507013
[TBL] [Abstract][Full Text] [Related]
37. Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles.
Sunoqrot S; Bugno J; Lantvit D; Burdette JE; Hong S
J Control Release; 2014 Oct; 191():115-22. PubMed ID: 24837188
[TBL] [Abstract][Full Text] [Related]
38. Impact of Nanoparticle Physicochemical Properties on Protein Corona and Macrophage Polarization.
Xiao B; Liu Y; Chandrasiri I; Overby C; Benoit DSW
ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36916683
[TBL] [Abstract][Full Text] [Related]
39. Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine.
Ju Y; Lee WS; Pilkington EH; Kelly HG; Li S; Selva KJ; Wragg KM; Subbarao K; Nguyen THO; Rowntree LC; Allen LF; Bond K; Williamson DA; Truong NP; Plebanski M; Kedzierska K; Mahanty S; Chung AW; Caruso F; Wheatley AK; Juno JA; Kent SJ
ACS Nano; 2022 Aug; 16(8):11769-11780. PubMed ID: 35758934
[TBL] [Abstract][Full Text] [Related]
40. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
